Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Inactivation as a new regulatory mechanism for neuronal Kv7 channels.
Jensen HS
,
Grunnet M
,
Olesen SP
.
???displayArticle.abstract???
Voltage-gated K(+) channels of the Kv7 (KCNQ) family have important physiological functions in both excitable and nonexcitable tissue. The family encompasses five genes encoding the channel subunits Kv7.1-5. Kv7.1 is found in epithelial and cardiac tissue. Kv7.2-5 channels are predominantly neuronal channels and are important for controlling excitability. Kv7.1 channels have been considered the only Kv7 channels to undergo inactivation upon depolarization. However, here we demonstrate that inactivation is also an intrinsic property of Kv7.4 and Kv7.5 channels, which inactivate to a larger extent than Kv7.1 channels at all potentials. We demonstrate that at least 30% of these channels are inactivated at physiologically relevant potentials. The onset of inactivation is voltage dependent and occurs on the order of seconds. Both time- and voltage-dependent recovery from inactivation was investigated for Kv7.4 channels. A time constant of 1.47 +/- 0.21 s and a voltage constant of 54.9 +/- 3.4 mV were determined. It was further demonstrated that heteromeric Kv7.3/Kv7.4 channels had inactivation properties different from homomeric Kv7.4 channels. Finally, the Kv7 channel activator BMS-204352 was in contrast to retigabine found to abolish inactivation of Kv7.4. In conclusion, this work demonstrates that inactivation is a key regulatory mechanism of Kv7.4 and Kv7.5 channels.
Angelo,
KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current.
2002, Pubmed,
Xenbase
Angelo,
KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current.
2002,
Pubmed
,
Xenbase
Barhanin,
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
1996,
Pubmed
,
Xenbase
Bentzen,
The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
2006,
Pubmed
,
Xenbase
Biervert,
A potassium channel mutation in neonatal human epilepsy.
1998,
Pubmed
,
Xenbase
Brown,
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone.
1980,
Pubmed
Charlier,
A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.
1998,
Pubmed
Coucke,
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families.
1999,
Pubmed
Cruzblanca,
Bradykinin inhibits M current via phospholipase C and Ca2+ release from IP3-sensitive Ca2+ stores in rat sympathetic neurons.
1998,
Pubmed
Dalby-Brown,
K(v)7 channels: function, pharmacology and channel modulators.
2006,
Pubmed
Delmas,
Pathways modulating neural KCNQ/M (Kv7) potassium channels.
2005,
Pubmed
Dupuis,
Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352.
2002,
Pubmed
Ford,
Experiments to test the role of phosphatidylinositol 4,5-bisphosphate in neurotransmitter-induced M-channel closure in bullfrog sympathetic neurons.
2003,
Pubmed
Gribkoff,
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.
2001,
Pubmed
Grunnet,
hKCNE4 inhibits the hKCNQ1 potassium current without affecting the activation kinetics.
2005,
Pubmed
,
Xenbase
Grunnet,
KCNE4 is an inhibitory subunit to the KCNQ1 channel.
2002,
Pubmed
,
Xenbase
Grunnet,
KCNQ1 channels sense small changes in cell volume.
2003,
Pubmed
,
Xenbase
Hansen,
The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
2006,
Pubmed
Hoshi,
Biophysical and molecular mechanisms of Shaker potassium channel inactivation.
1990,
Pubmed
,
Xenbase
Hougaard,
Modulation of KCNQ4 channel activity by changes in cell volume.
2004,
Pubmed
Jensen,
The KCNQ5 potassium channel from mouse: a broadly expressed M-current like potassium channel modulated by zinc, pH, and volume changes.
2005,
Pubmed
,
Xenbase
Jentsch,
Neuronal KCNQ potassium channels: physiology and role in disease.
2000,
Pubmed
Jespersen,
The KCNQ1 potassium channel: from gene to physiological function.
2005,
Pubmed
Kharkovets,
KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway.
2000,
Pubmed
Korsgaard,
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
2005,
Pubmed
,
Xenbase
Kubisch,
KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness.
1999,
Pubmed
,
Xenbase
Lerche,
Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity.
2000,
Pubmed
,
Xenbase
Li,
Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
2004,
Pubmed
Liu,
Dynamic rearrangement of the outer mouth of a K+ channel during gating.
1996,
Pubmed
Loussouarn,
Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels.
2003,
Pubmed
Marx,
Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.
2002,
Pubmed
Peretz,
Modulation of homomeric and heteromeric KCNQ1 channels by external acidification.
2002,
Pubmed
,
Xenbase
Potet,
AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IsK channel complex.
2001,
Pubmed
Pusch,
Activation and inactivation of homomeric KvLQT1 potassium channels.
1998,
Pubmed
,
Xenbase
Rettig,
Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit.
1994,
Pubmed
,
Xenbase
Robbins,
KCNQ potassium channels: physiology, pathophysiology, and pharmacology.
2001,
Pubmed
Romey,
Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity.
1997,
Pubmed
Roux,
Fast inactivation in Shaker K+ channels. Properties of ionic and gating currents.
1998,
Pubmed
,
Xenbase
Sanguinetti,
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
1996,
Pubmed
,
Xenbase
Schrøder,
KCNQ4 channel activation by BMS-204352 and retigabine.
2001,
Pubmed
Schrøder,
Voltage-independent KCNQ4 currents induced by (+/-)BMS-204352.
2003,
Pubmed
Schroeder,
A constitutively open potassium channel formed by KCNQ1 and KCNE3.
2000,
Pubmed
,
Xenbase
Schroeder,
KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents.
2000,
Pubmed
Schroeder,
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.
1998,
Pubmed
,
Xenbase
Seebohm,
Regulation of KCNQ4 potassium channel prepulse dependence and current amplitude by SGK1 in Xenopus oocytes.
2005,
Pubmed
,
Xenbase
Seebohm,
Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome.
2001,
Pubmed
,
Xenbase
Selyanko,
Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.
2001,
Pubmed
Shapiro,
Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.
2000,
Pubmed
Simmons,
Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
1994,
Pubmed
Singh,
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.
1998,
Pubmed
Suh,
Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis.
2002,
Pubmed
Talebizadeh,
Novel mutation in the KCNQ4 gene in a large kindred with dominant progressive hearing loss.
1999,
Pubmed
Tatulian,
Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells.
2003,
Pubmed
Tatulian,
Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
2001,
Pubmed
Tinel,
KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel.
2000,
Pubmed
,
Xenbase
Tristani-Firouzi,
Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits.
1998,
Pubmed
,
Xenbase
Unsöld,
KCNE1 reverses the response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and sensitivity to temperature.
2000,
Pubmed
,
Xenbase
Wang,
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
1998,
Pubmed
,
Xenbase
Wang,
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias.
1996,
Pubmed
Zhang,
PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents.
2003,
Pubmed
,
Xenbase
